NM_001127222.2:c.6013G>A

Variant summary

Our verdict is Benign. The variant received -7 ACMG points: 0P and 7B. BP4_ModerateBP6BS2

The NM_001127222.2(CACNA1A):​c.6013G>A​(p.Ala2005Thr) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000218 in 1,512,660 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Synonymous variant affecting the same amino acid position (i.e. A2005A) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.000046 ( 0 hom., cov: 32)
Exomes 𝑓: 0.000019 ( 0 hom. )

Consequence

CACNA1A
NM_001127222.2 missense

Scores

7
12

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:1B:3

Conservation

PhyloP100: 3.06

Publications

2 publications found
Variant links:
Genes affected
CACNA1A (HGNC:1388): (calcium voltage-gated channel subunit alpha1 A) Voltage-dependent calcium channels mediate the entry of calcium ions into excitable cells, and are also involved in a variety of calcium-dependent processes, including muscle contraction, hormone or neurotransmitter release, and gene expression. Calcium channels are multisubunit complexes composed of alpha-1, beta, alpha-2/delta, and gamma subunits. The channel activity is directed by the pore-forming alpha-1 subunit, whereas, the others act as auxiliary subunits regulating this activity. The distinctive properties of the calcium channel types are related primarily to the expression of a variety of alpha-1 isoforms, alpha-1A, B, C, D, E, and S. This gene encodes the alpha-1A subunit, which is predominantly expressed in neuronal tissue. Mutations in this gene are associated with 2 neurologic disorders, familial hemiplegic migraine and episodic ataxia 2. This gene also exhibits polymorphic variation due to (CAG)n-repeats. Multiple transcript variants encoding different isoforms have been found for this gene. In one set of transcript variants, the (CAG)n-repeats occur in the 3' UTR, and are not associated with any disease. But in another set of variants, an insertion extends the coding region to include the (CAG)n-repeats which encode a polyglutamine tract. Expansion of the (CAG)n-repeats from the normal 4-18 to 21-33 in the coding region is associated with spinocerebellar ataxia 6. [provided by RefSeq, Jul 2016]
CACNA1A Gene-Disease associations (from GenCC):
  • episodic ataxia type 2
    Inheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Orphanet, Ambry Genetics, Genomics England PanelApp, Labcorp Genetics (formerly Invitae)
  • undetermined early-onset epileptic encephalopathy
    Inheritance: AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: Orphanet, Illumina
  • developmental and epileptic encephalopathy, 42
    Inheritance: AD Classification: STRONG, MODERATE Submitted by: G2P, Ambry Genetics, Labcorp Genetics (formerly Invitae)
  • migraine, familial hemiplegic, 1
    Inheritance: AD Classification: STRONG Submitted by: Ambry Genetics, Genomics England PanelApp, Labcorp Genetics (formerly Invitae)
  • spinocerebellar ataxia type 6
    Inheritance: AD Classification: STRONG, SUPPORTIVE Submitted by: Ambry Genetics, Genomics England PanelApp, Labcorp Genetics (formerly Invitae), Orphanet
  • benign paroxysmal torticollis of infancy
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • familial or sporadic hemiplegic migraine
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • Lennox-Gastaut syndrome
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -7 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.08892241).
BP6
Variant 19-13212668-C-T is Benign according to our data. Variant chr19-13212668-C-T is described in ClinVar as Conflicting_classifications_of_pathogenicity. ClinVar VariationId is 446936.
BS2
High AC in GnomAd4 at 7 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
CACNA1ANM_001127222.2 linkc.6013G>A p.Ala2005Thr missense_variant Exon 41 of 47 ENST00000360228.11 NP_001120694.1
CACNA1ANM_001127221.2 linkc.6016G>A p.Ala2006Thr missense_variant Exon 41 of 47 ENST00000638009.2 NP_001120693.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
CACNA1AENST00000360228.11 linkc.6013G>A p.Ala2005Thr missense_variant Exon 41 of 47 1 NM_001127222.2 ENSP00000353362.5
CACNA1AENST00000638009.2 linkc.6016G>A p.Ala2006Thr missense_variant Exon 41 of 47 1 NM_001127221.2 ENSP00000489913.1
CACNA1AENST00000638029.1 linkc.6031G>A p.Ala2011Thr missense_variant Exon 42 of 48 5 ENSP00000489829.1
CACNA1AENST00000573710.7 linkc.6019G>A p.Ala2007Thr missense_variant Exon 41 of 47 5 ENSP00000460092.3
CACNA1AENST00000635727.1 linkc.6016G>A p.Ala2006Thr missense_variant Exon 41 of 47 5 ENSP00000490001.1
CACNA1AENST00000637769.1 linkc.6016G>A p.Ala2006Thr missense_variant Exon 41 of 47 1 ENSP00000489778.1
CACNA1AENST00000636012.1 linkc.6016G>A p.Ala2006Thr missense_variant Exon 41 of 46 5 ENSP00000490223.1
CACNA1AENST00000637736.1 linkc.5875G>A p.Ala1959Thr missense_variant Exon 40 of 46 5 ENSP00000489861.1
CACNA1AENST00000636389.1 linkc.6016G>A p.Ala2006Thr missense_variant Exon 41 of 47 5 ENSP00000489992.1
CACNA1AENST00000637432.1 linkc.6031G>A p.Ala2011Thr missense_variant Exon 42 of 48 5 ENSP00000490617.1
CACNA1AENST00000636549.1 linkc.6022G>A p.Ala2008Thr missense_variant Exon 42 of 48 5 ENSP00000490578.1
CACNA1AENST00000637927.1 linkc.6019G>A p.Ala2007Thr missense_variant Exon 41 of 47 5 ENSP00000489715.1
CACNA1AENST00000635895.1 linkc.6016G>A p.Ala2006Thr missense_variant Exon 41 of 47 5 ENSP00000490323.1
CACNA1AENST00000637276.1 linkc.6016G>A p.Ala2006Thr missense_variant Exon 41 of 46 5 ENSP00000489777.1
CACNA1AENST00000636768.2 linkn.*315G>A non_coding_transcript_exon_variant Exon 40 of 45 5 ENSP00000490190.2
CACNA1AENST00000713789.1 linkn.*1228G>A non_coding_transcript_exon_variant Exon 42 of 47 ENSP00000519091.1
CACNA1AENST00000636768.2 linkn.*315G>A 3_prime_UTR_variant Exon 40 of 45 5 ENSP00000490190.2
CACNA1AENST00000713789.1 linkn.*1228G>A 3_prime_UTR_variant Exon 42 of 47 ENSP00000519091.1

Frequencies

GnomAD3 genomes
AF:
0.0000461
AC:
7
AN:
152006
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.0000655
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.000580
Gnomad SAS
AF:
0.000415
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000147
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.0000690
AC:
11
AN:
159378
AF XY:
0.0000714
show subpopulations
Gnomad AFR exome
AF:
0.0000811
Gnomad AMR exome
AF:
0.0000491
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.000549
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.00
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.0000191
AC:
26
AN:
1360536
Hom.:
0
Cov.:
33
AF XY:
0.0000195
AC XY:
13
AN XY:
665500
show subpopulations
African (AFR)
AF:
0.0000329
AC:
1
AN:
30364
American (AMR)
AF:
0.0000336
AC:
1
AN:
29718
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
19916
East Asian (EAS)
AF:
0.000417
AC:
16
AN:
38350
South Asian (SAS)
AF:
0.0000575
AC:
4
AN:
69538
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
49140
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5016
European-Non Finnish (NFE)
AF:
0.00000188
AC:
2
AN:
1062540
Other (OTH)
AF:
0.0000357
AC:
2
AN:
55954
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.475
Heterozygous variant carriers
0
1
3
4
6
7
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0000460
AC:
7
AN:
152124
Hom.:
0
Cov.:
32
AF XY:
0.0000269
AC XY:
2
AN XY:
74376
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
41504
American (AMR)
AF:
0.0000654
AC:
1
AN:
15280
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3468
East Asian (EAS)
AF:
0.000581
AC:
3
AN:
5164
South Asian (SAS)
AF:
0.000415
AC:
2
AN:
4814
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10600
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.0000147
AC:
1
AN:
67982
Other (OTH)
AF:
0.00
AC:
0
AN:
2106
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.489
Heterozygous variant carriers
0
1
1
2
2
3
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00
Hom.:
0
Bravo
AF:
0.0000378
ESP6500AA
AF:
0.00
AC:
0
ESP6500EA
AF:
0.000121
AC:
1
ExAC
AF:
0.0000423
AC:
5
Asia WGS
AF:
0.00346
AC:
12
AN:
3478

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:1Benign:3
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

not provided Benign:2
-
Diagnostic Laboratory, Department of Genetics, University Medical Center Groningen
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

-
Genome Diagnostics Laboratory, University Medical Center Utrecht
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

not specified Uncertain:1
Feb 09, 2017
Athena Diagnostics
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Episodic ataxia type 2;C4310716:Developmental and epileptic encephalopathy, 42 Benign:1
Oct 24, 2024
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.071
BayesDel_addAF
Benign
-0.14
T
BayesDel_noAF
Uncertain
-0.080
CADD
Uncertain
24
DANN
Benign
0.79
DEOGEN2
Benign
0.014
.;.;T;.;.;.;.;.;T;.;.;T;.;.;.;T;.;.
Eigen
Benign
-0.31
Eigen_PC
Benign
-0.22
FATHMM_MKL
Uncertain
0.84
D
LIST_S2
Uncertain
0.87
D;D;D;D;D;D;D;D;D;D;.;D;D;D;D;D;D;D
M_CAP
Uncertain
0.12
D
MetaRNN
Benign
0.089
T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T
MetaSVM
Uncertain
0.15
D
MutationAssessor
Uncertain
2.3
.;.;.;.;M;.;.;.;.;.;.;.;.;.;M;.;.;.
PhyloP100
3.1
PrimateAI
Uncertain
0.59
T
PROVEAN
Benign
-0.80
.;N;.;.;.;.;.;.;.;.;.;.;.;.;.;.;.;.
REVEL
Benign
0.26
Sift
Benign
0.33
.;T;.;.;.;.;.;.;.;.;.;.;.;.;.;.;.;.
Sift4G
Benign
0.47
T;T;.;.;.;T;.;.;.;.;.;.;.;.;.;.;.;.
Vest4
0.28
MVP
0.88
MPC
0.68
ClinPred
0.050
T
GERP RS
2.4
Varity_R
0.055
gMVP
0.22
Mutation Taster
=93/7
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs374063403; hg19: chr19-13323482; API